Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. | Nat Commun | 2021 | 34373451 | PubTator, text mining | PubMed |
| Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1. | Nutrients | 2021 | 34371910 | PubTator, text mining | PubMed |
| Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths. | Dis Model Mech | 2021 | 34370008 | PubTator, text mining | PubMed |
| SMN protein is required throughout life to prevent spinal muscular atrophy disease progression. | Hum Mol Genet | 2021 | 34368854 | PubTator, text mining | PubMed |
| Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA). | Int J Mol Sci | 2021 | 34360794 | PubTator, text mining | PubMed |
| Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development. | Int J Mol Sci | 2021 | 34360669 | PubTator, text mining | PubMed |
| Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy. | Clin Pharmacol Ther | 2021 | 34347881 | PubTator, text mining | PubMed |
| Splicing modulators: on the way from nature to clinic. | J Antibiot (Tokyo) | 2021 | 34345042 | PubTator, text mining | PubMed |
| [Molecular medicine: pathobiochemistry as the key to personalized treatment of inherited diseases]. | Monatsschr Kinderheilkd | 2021 | 34341617 | PubTator, text mining | PubMed |
| Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine. | Cell Rep Med | 2021 | 34337562 | PubTator, text mining | PubMed |
| Alternative splicing of mRNA in colorectal cancer: new strategies for tumor diagnosis and treatment. | Cell Death Dis | 2021 | 34330892 | PubTator, text mining | PubMed |
| Different trajectories in upper limb and gross motor function in spinal muscular atrophy. | Muscle Nerve | 2021 | 34327716 | PubTator, text mining | PubMed |
| Regulated control of gene therapies by drug-induced splicing. | Nature | 2021 | 34321659 | PubTator, text mining | PubMed |
| Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy. | Orphanet J Rare Dis | 2021 | 34321067 | PubTator, text mining | PubMed |
| Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls. | N Engl J Med | 2021 | 34320287 | PubTator, text mining | PubMed |
| SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replication. | RNA | 2021 | 34315816 | PubTator, text mining | PubMed |
| Interventions for spinal muscular atrophy: an impetus for newborn screening. | EBioMedicine | 2021 | 34315607 | PubTator, text mining | PubMed |
| Evaluation of putative CSF biomarkers in paediatric spinal muscular atrophy (SMA) patients before and during treatment with nusinersen. | J Cell Mol Med | 2021 | 34312963 | PubTator, text mining | PubMed |
| A novel zebrafish model for intermediate type spinal muscular atrophy demonstrates importance of Smn for maintenance of mature motor neurons. | Hum Mol Genet | 2021 | 34302176 | PubTator, text mining | PubMed |
| Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. | Nat Commun | 2021 | 34301951 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=61